| Company Name: | Diomed Holdings, Incorporated | | Ticker Symbol: | DIO | | | WWW Address: | www.diomedinc.com | | CEO: | James A. Wylie, Jr. | | No. of Employees: | 100 | | Common Issue Type: | CS | | Business Description: | The Company develops and commercializes minimally invasive medical procedures that employ its laser technologies and associated disposable products.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.0231 |  0.0 | - | - | 0 | 0.05 | 0.02 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 0.7 | 30.3 | 3.11 | -0.75 | 0.00 | 0.0 | 0.0 | 3.50 - 0.02 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.02 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 0.7 | mil |
| Latest Shares Outstanding | 30.3 | mil |
| Earnings pS (EPS) | -0.75 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 223,823 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 28.4 | mil |
| Float as % of Shares Outstanding | 93.7 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 92.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 6.40 | % |
| Gross Profit Margin | 49.5 | % |
| EBITDA Margin | -49.2 | % |
| Pre-Tax Profit Margin | -58.0 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | -63.1 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -135.6 | % |
| Current Ratio | 1.4 | |
| Leverage Ratio (Assets/Equity) | 4.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 1.08 | |
| LT Debt/Total Capital | 47.0 | % |
| Working Capital pS | 0.16 | $ |
| Cash pS | 0.24 | $ |
| Book-Value pS | 0.19 | $ |
| Tangible Book-Value pS | 0.07 | $ |
| Cash Flow pS | -0.50 | $ |
| Free Cash Flow pS | -0.34 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.12 | |
| Price/Tangible Book Ratio | 0.33 | |
| Price/Cash Flow | 0.0 | |
| Price/Free Cash Flow | -0.1 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 97 | 6,815 | 0 |
| 4 Weeks | 0.23 | 0.02 | 0.22 | -90.9 | 9 | 4,350 | 73,957 |
| 13 Weeks | 0.37 | 0.02 | 0.31 | -93.5 | 7 | 2,115 | 122,664 |
| 26 Weeks | 0.87 | 0.02 | 0.69 | -97.1 | 3 | 2,010 | 245,221 |
| 52 Weeks | 3.50 | 0.02 | 1.03 | -98.1 | 2 | 2,663 | 660,394 |
| YTD | 0.37 | 0.02 | - | -93.8 | 7 | 2,093 | 110,911 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.03 | 0.10 | 0.21 | 0.44 | 0.60 | 3.11 | 2.59 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.00 | 0.0 | 22.99 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | -32.71 |
| R&D | 0.00 | NA | 4.64 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 17.5 | 19.4 | 17.5 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.00 | 0.06 | -0.08 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 49.24 |
| Current Ratio | 3.1 |
| Quick Ratio (Acid Test) | 2.3 |
| Liquidity Ratio (Cash) | 1.76 |
| Receivables Turnover | 7.5 |
| Average Collection Period | 48 |
| Working Capital/Equity | -280.8 |
| Working Capital pS | 0.60 |
| Cash-Flow pS | -0.70 |
| Free Cash-Flow pS | -0.60 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -0.61 |
| Financial Leverage Ratio (Assets/Equity) | 0.0 |
| Debt Ratio | 28.4 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 6.4 |
| LT Debt/Total Liabilities | 15.4 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 3.66 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.05 |
| Tobin's Q Ratio | 0.03 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -1.97 |
| Enterprise Value (EV)/Free Cash Flow | -2.97 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.33 |
| Price/Book Ratio - LTM | 0.12 |
| Price/Cash Flow Ratio | 0.0 |
| Price/Free Cash Flow Ratio - LTM | -0.1 |
| Price/Sales Ratio | 0.03 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.05 |
| Current Liabilities pS | 0.29 |
| Tangible Book Value pS - LTM | 0.07 |
| Book Value pS - LTM | 0.19 |
| Capital Invested pS | 0.60 |
| Cash pS - LTM | 0.24 |
| Cash Flow pS - LTM | -0.50 |
| Free Cash Flow pS - LTM | -0.34 |
| Earnings pS (EPS) | -0.75 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -51.70 |
| Free Cash Flow Margin 5YEAR AVG | -79.91 |
| Net Profit Margin | -45.9 |
| Net Profit Margin - 5YEAR AVRG. | -85.8 |
| Equity Productivity | -5.35 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.24 |
| Return on Capital Invested (ROCI) | -56.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -87.1 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | -43.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | -56.8 |
| Gross Profit Margin | 49.5 |
| Gross Profit Margin - 5YEAR AVRG. | 47.5 |
| EBITDA Margin - LTM | -49.2 |
| EBIT Margin - LTM | -52.9 |
| Pre-Tax Profit Margin | -45.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -85.8 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 0.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 164 |
| Revenue per Employee | 223,823 |
| Net Income per Employee | -102,690 |
| Average Collection Period | 51 |
| Receivables Turnover | 7.5 |
| Day's Inventory Turnover Ratio | 113 |
| Inventory Turnover | 3.2 |
| Inventory/Sales | 18.0 |
| Accounts Payble/Sales | 13.27 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 1.91 |
| Fixed Assets Turnover | 3.46 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 3.06 |
| Revenue per $ Plant | 17.76 |
| Revenue per $ Common Equity | -5.35 |
| Revenue per $ Capital Invested | 1.24 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 85.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 94.2 |
| Research & Devlopment (R&D) as % of Revenue | 6.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 6.7 |
|
|  
|
| |
 |  |